Evidence map›Paper›PMID 35883154›Full record

ArticleBioData mining2022

Benchmarking AutoML frameworks for disease prediction using medical claims.

Roland Albert A Romero, Mariefel Nicole Y Deypalan, Suchit Mehrotra, John Titus Jungao, Natalie E Sheils, Elisabetta Manduchi, Jason H Moore

Abstract read
In one paragraph

Article in BioData mining, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Roland Albert A RomeroOptumLabs, Minnetonka, 55343, MN, USA.
Mariefel Nicole Y DeypalanOptumLabs, Minnetonka, 55343, MN, USA.
Suchit MehrotraOptumLabs, Minnetonka, 55343, MN, USA.
John Titus JungaoOptumLabs, Minnetonka, 55343, MN, USA.
Natalie E SheilsOptumLabs, Minnetonka, 55343, MN, USA.
Elisabetta ManduchiDepartment of Computational Biomedicine, Cedars-Sinai Medical Center, 700 N. San Vicente Blvd., Pacific Design Center Suite G540, West Hollywood, 90069, CA, USA.
Jason H MooreDepartment of Computational Biomedicine, Cedars-Sinai Medical Center, 700 N. San Vicente Blvd., Pacific Design Center Suite G540, West Hollywood, 90069, CA, USA. jason.moore@csmc.edu.ORCID http://orcid.org/0000-0002-5015-1099

Funding

Bioinformatics Strategies for Genome-Wide Association StudiesR01LM010098 · NLM · UNIVERSITY OF PENNSYLVANIA · PI MOORE, JASON H., WILLIAMS, SCOTT MATTHEW · 2009 to 2023
$5.1M
NIH HHS LM010098NLM NIH HHS R01 LM010098
6 · The paper itself

Abstract

objectivesAscertain and compare the performances of Automated Machine Learning (AutoML) tools on large, highly imbalanced healthcare datasets. MATERIALS AND

methodsWe generated a large dataset using historical de-identified administrative claims including demographic information and flags for disease codes in four different time windows prior to 2019. We then trained three AutoML tools on this dataset to predict six different disease outcomes in 2019 and evaluated model performances on several metrics.

resultsThe AutoML tools showed improvement from the baseline random forest model but did not differ significantly from each other. All models recorded low area under the precision-recall curve and failed to predict true positives while keeping the true negative rate high. Model performance was not directly related to prevalence. We provide a specific use-case to illustrate how to select a threshold that gives the best balance between true and false positive rates, as this is an important consideration in medical applications. DISCUSSION: Healthcare datasets present several challenges for AutoML tools, including large sample size, high imbalance, and limitations in the available features. Improvements in scalability, combinations of imbalance-learning resampling and ensemble approaches, and curated feature selection are possible next steps to achieve better performance.

conclusionAmong the three explored, no AutoML tool consistently outperforms the rest in terms of predictive performance. The performances of the models in this study suggest that there may be room for improvement in handling medical claims data. Finally, selection of the optimal prediction threshold should be guided by the specific practical application.

Indexed as

Automated machine learningAutoMLClass imbalanceHealthcareMachine learningMedical claims

Identifiers

PMID35883154
PMCPMC9327416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.